Axsome Therapeutics to Participate in Investor Conferences in September
Axsome Therapeutics (NASDAQ: AXSM), a biopharmaceutical company focused on central nervous system (CNS) disorders, has announced its participation in four major investor conferences in September 2024:
1. Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York (presentation at 4:50 p.m. ET)
2. Wells Fargo Healthcare Conference on September 5 in Boston (investor meetings)
3. Baird 2024 Global Healthcare Conference on September 11 in New York (presentation at 8:30 a.m. ET)
4. Cantor Global Healthcare Conference on September 18 in New York (presentation at 9:45 a.m. ET)
Live webcasts of the presentations at the Morgan Stanley and Cantor conferences will be available on Axsome's website, with replays accessible for approximately 30 days after each event.
Axsome Therapeutics (NASDAQ: AXSM), una compagnia biofarmaceutica focalizzata sui disturbi del sistema nervoso centrale (SNC), ha annunciato la sua partecipazione a quattro importanti conferenze per investitori a settembre 2024:
1. 22ª Conferenza Annuale Globale sulla Salute di Morgan Stanley il 4 settembre a New York (presentazione alle 16:50 ET)
2. Conferenza sulla Salute di Wells Fargo il 5 settembre a Boston (incontri con gli investitori)
3. Conferenza Globale sulla Salute di Baird 2024 l'11 settembre a New York (presentazione alle 8:30 ET)
4. Conferenza Globale sulla Salute di Cantor il 18 settembre a New York (presentazione alle 9:45 ET)
Le dirette web delle presentazioni alle conferenze di Morgan Stanley e Cantor saranno disponibili sul sito web di Axsome, con repliche accessibili per circa 30 giorni dopo ciascun evento.
Axsome Therapeutics (NASDAQ: AXSM), una compañía biofarmacéutica enfocada en trastornos del sistema nervioso central (SNC), ha anunciado su participación en cuatro importantes conferencias para inversores en septiembre de 2024:
1. 22ª Conferencia Anual Global de Salud de Morgan Stanley el 4 de septiembre en Nueva York (presentación a las 4:50 p.m. ET)
2. Conferencia de Salud de Wells Fargo el 5 de septiembre en Boston (reuniones con inversores)
3. Conferencia Global de Salud de Baird 2024 el 11 de septiembre en Nueva York (presentación a las 8:30 a.m. ET)
4. Conferencia Global de Salud de Cantor el 18 de septiembre en Nueva York (presentación a las 9:45 a.m. ET)
Las transmisiones en vivo de las presentaciones en las conferencias de Morgan Stanley y Cantor estarán disponibles en el sitio web de Axsome, con repeticiones accesibles durante aproximadamente 30 días después de cada evento.
악솜 테라퓨틱스 (NASDAQ: AXSM), 중추 신경계(CNS) 질환에 집중하는 생명공학 회사가 2024년 9월에 열리는 4개의 주요 투자자 회의에 참여할 것이라고 발표했습니다:
1. 모건 스탠리 제22회 연례 글로벌 헬스케어 회의가 9월 4일 뉴욕에서 개최 (동부 표준시 16:50 발표)
2. 웰스 파고 헬스케어 회의가 9월 5일 보스턴에서 개최 (투자자 회의)
3. 베어드 2024 글로벌 헬스케어 회의가 9월 11일 뉴욕에서 개최 (동부 표준시 8:30 발표)
4. 칸토 글로벌 헬스케어 회의가 9월 18일 뉴욕에서 개최 (동부 표준시 9:45 발표)
모건 스탠리와 칸토 회의에서의 발표 생중계는 악솜의 웹사이트에서 이용 가능하며 각 이벤트 후 약 30일 동안 다시 보기 서비스를 제공합니다.
Axsome Therapeutics (NASDAQ: AXSM), une entreprise bio-pharmaceutique spécialisée dans les troubles du système nerveux central (SNC), a annoncé sa participation à quatre grandes conférences d'investisseurs en septembre 2024 :
1. 22ème Conférence Annuelle Mondiale de la Santé de Morgan Stanley le 4 septembre à New York (présentation à 16h50 ET)
2. Conférence Santé de Wells Fargo le 5 septembre à Boston (réunions avec les investisseurs)
3. Conférence Mondiale de la Santé de Baird 2024 le 11 septembre à New York (présentation à 8h30 ET)
4. Conférence Mondiale de la Santé de Cantor le 18 septembre à New York (présentation à 9h45 ET)
Des diffusions en direct des présentations aux conférences de Morgan Stanley et Cantor seront disponibles sur le site web d'Axsome, avec des rediffusions accessibles pendant environ 30 jours après chaque événement.
Axsome Therapeutics (NASDAQ: AXSM), ein biopharmazeutisches Unternehmen, das sich auf Erkrankungen des zentralen Nervensystems (ZNS) konzentriert, hat seine Teilnahme an vier wichtigen Investorenkonferenzen im September 2024 angekündigt:
1. 22. Internationale Gesundheitskonferenz von Morgan Stanley am 4. September in New York (Präsentation um 16:50 Uhr ET)
2. Wells Fargo Gesundheitskonferenz am 5. September in Boston (Investorengespräche)
3. Baird 2024 Globale Gesundheitskonferenz am 11. September in New York (Präsentation um 8:30 Uhr ET)
4. Cantor Globale Gesundheitskonferenz am 18. September in New York (Präsentation um 9:45 Uhr ET)
Die Live-Übertragungen der Präsentationen bei den Morgan Stanley- und Cantor-Konferenzen werden auf der Website von Axsome verfügbar sein, mit Wiederholungen, die etwa 30 Tage nach jeder Veranstaltung zugänglich sind.
- None.
- None.
Morgan Stanley 22nd Annual Global Healthcare Conference on September 4 in New York
Wells Fargo Healthcare Conference on September 5 in Boston
Baird 2024 Global Healthcare Conference on September 11 in New York
Cantor Global Healthcare Conference on September 18 in New York
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, will participate in four investor conferences in September:
- Morgan Stanley 22nd Annual Global Healthcare Conference
The Company will present on Wednesday, September 4, 2024 at 4:50 p.m. ET in New York, NY
- 2024 Wells Fargo Healthcare Conference
The Company will participate in investor meetings on Thursday, September 5, 2024 in Boston, MA
- Baird 2024 Global Healthcare Conference
The Company will present on Wednesday, September 11, 2024 at 8:30 a.m. ET in New York, NY
- 2024 Cantor Global Healthcare Conference
The Company will present on Wednesday, September 18, 2024 at 9:45 a.m. ET in New York, NY
Live webcasts of the presentations at the Morgan Stanley and Cantor conferences can be accessed on the Investors page of the Company’s website at www.axsome.com. Replays of the webcasts will be available for approximately 30 days following each event.
About Axsome Therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are committed to developing products that meaningfully improve the lives of patients and provide new therapeutic options for physicians. For more information, please visit the Company’s website at www.axsome.com.
Investors:
Mark Jacobson
Chief Operating Officer
(212) 332-3243
mjacobson@axsome.com
Media:
Darren Opland
Director, Corporate Communications
(929) 837-1065
dopland@axsome.com
FAQ
Which investor conferences will Axsome Therapeutics (AXSM) attend in September 2024?
When and where will Axsome Therapeutics (AXSM) present at the Morgan Stanley conference?
Will Axsome Therapeutics (AXSM) provide webcasts of their conference presentations?
How long will the replays of Axsome Therapeutics (AXSM) conference presentations be available?
